Discover 657 paid clinical trials in Charleston, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 657
Efficacy of Intramuscular Steroid Injection for Chronic Cough.
for
Chronic Cough (CC), Laryngeal Disease, Coughing
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06634823
Early Phase 1, Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Charleston SC, Duarte CA, Portland OR
Sponsor: Adela, Inc
Sex: All
Age: 40+
Code: NCT05366881
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Optimizing Tobacco Treatment Delivery for People Living With HIV
for
Hiv, Smoking, Cigarette
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 21+
Code: NCT05019495
Recruiting
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for
Breast Atypical Ductal Hyperplasia,
Location: Charleston SC, Cleveland OH, Ann Arbor MI, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18 - 55
Code: NCT06184750
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Charleston SC, Augusta GA, Union SC, Spartanburg SC,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase 2, Recruiting
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
for
Subcutaneous ICD, Myopotential Interference
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05766943
Recruiting
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
for
Primary Immune Deficiency
Location: Charleston SC
Sponsor: ADMA Biologics, Inc.
Sex: All
Age: 2 - 11
Code: NCT05070455
Recruiting
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma